Microvillus inclusion disease is an inherited intestinal brush border membrane defect that causes severe fluid and electrolyte malabsorption. In an infant with microvillus inclusion disease (confirmed by electron microscopic evaluation of rectal, jejunal, and gallbladder mucosae), basal stool output was massive (greater than 125 mL . kg-1 . day-1) and was not altered by treatment with clonidine or octreotide. A proximal jejunostomy with mucous fistula was placed, allowing separation of proximal from distal tract outputs (60 mL . kg-1 . day-1 and 100 mL . kg-1 . day-1, respectively). A 10-cm jejunal segment was excised during surgery and mounted in Ussing chambers for determination of transepithelial Na+ and Cl fluxes. Compared with intestine of normal infants, this infant's epithelium showed transmural conductance and unidirectional ion fluxes that were only 30% of normal. With respect to both Na+ and Cl, the excised jejunum was in a net secretory state. Theophylline (5 mmol/L) increased net Cl secretion slightly. In response to mucosal D-glucose (30 mmol/L), jejunal mucosal-to-serosal Na+ flux doubled. In the infant, glucose-electrolyte solution administered intrajejunally did not significantly change stool output, suggesting that all of the solution (40 mL/kg) was absorbed. Subtotal enterocolectomy, in theory, could have decreased purging by 66% in this infant with microvillus inclusion disease, but diarrhea would still have been significant.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0016-5085(91)80031-4DOI Listing

Publication Analysis

Top Keywords

microvillus inclusion
16
inclusion disease
16
kg-1 day-1
12
infant microvillus
8
stool output
8
microvillus
4
disease
4
disease vitro
4
jejunal
4
vitro jejunal
4

Similar Publications

SLC26A3 (DRA, the Congenital Chloride Diarrhea Gene): A Novel Therapeutic Target for Diarrheal Diseases.

Cell Mol Gastroenterol Hepatol

December 2024

- Division of Gastroenterology and Hepatology, Department of Medicine, University of Illinois, Chicago, IL, USA; - Jesse Brown VA Medical Center, Chicago, IL, USA. Electronic address:

Diarrhea associated with enteric infections, gut inflammation, and genetic defects poses a major health burden and results in significant morbidity and mortality. Impaired fluid and electrolyte absorption and/or secretion in the intestine are the hallmark of diarrhea. Electroneutral NaCl absorption in the mammalian GI tract involves the coupling of Na/H and Cl/HCO exchangers.

View Article and Find Full Text PDF

Is LPAR5 agonist a new treatment for microvilli inclusion disease?

Am J Physiol Gastrointest Liver Physiol

January 2025

Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States.

View Article and Find Full Text PDF
Article Synopsis
  • Syntaxin 3 is part of a protein family crucial for the fusion of vesicles with membranes, impacting various cellular processes.
  • Mutations in the syntaxin 3A splice form are linked to a serious gut disorder, while additional mutations involving syntaxin 3B can lead to early-onset retinal diseases.
  • The review focuses on new research highlighting the functions of syntaxin 3B in membrane fusion and neurotransmitter release specifically in the vertebrate retina.
View Article and Find Full Text PDF

Functional loss of the motor protein myosin Vb (MYO5B) induces various defects in intestinal epithelial function and causes a congenital diarrheal disorder, namely, microvillus inclusion disease (MVID). Utilizing the MVID model mice (MYO5BΔIEC) and [MYO5B(G519R)], we previously reported that functional MYO5B loss disrupts progenitor cell differentiation and enterocyte maturation that result in villus blunting and deadly malabsorption symptoms. In this study, we determined that both absence and a point mutation of MYO5B impair lipid metabolism and alter mitochondrial structure, which may underlie the progenitor cell malfunction observed in the MVID intestine.

View Article and Find Full Text PDF
Article Synopsis
  • - Functional loss of the motor protein MYO5B leads to serious intestinal issues, including microvillus inclusion disease (MVID), characterized by progenitor cell dysfunction and malabsorption symptoms.
  • - Research using MVID model mice showed that both the absence and mutation of MYO5B disrupt lipid metabolism and mitochondrial structure, resulting in reduced fatty acid oxidation and altered energy metabolism.
  • - Treatment with Compound-1, which targets LPAR5, was found to improve intestinal function and weight loss in mice with MYO5B mutations, suggesting a potential therapeutic approach for treating MVID.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!